Primary Recipient

ST LUKE'S-ROOSEVELT HOSPITAL CENTER

Amount

$157,716.00

Award Date

9/24/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The purpose of the supplement is to accelerate the pace of the scientific research in the parent grant NS061646. The overall objective of this grant, now, in its second year of funding, is to investigate the effects of antiviral drugs on HIV-1 replicatio

Vendors Connected to Award

Vendor	Role	Amount
Fisher Healthcare	Primary vendor	$628.99
Sigma-Aldrich Inc.	Primary vendor	$529.40
Applied BioSystems	Primary vendor	$1,433.52
Genewiz Inc.	Primary vendor	$28.00
Invitrogen Corp	Primary vendor	$262.58
LGM Pharma	Primary vendor	$1,480.00
Qiagen Inc.	Primary vendor	$4,271.00
Roche Diagnostics	Primary vendor	$1,215.82
Beckman Coulter Inc.	Primary vendor	$27.80
Promega	Primary vendor	$576.00
Jackson Immuno Research	Primary vendor	$77.00
Perkin Elmer	Primary vendor	$130.00
Accurate Chem Scientific	Primary vendor	$52.00
Millipore Corp	Primary vendor	$379.00
Omega Scientific	Primary vendor	$1,604.00
FDSI Logistics	Primary vendor	$62.76
BD Biosciences	Primary vendor	$175.00
Baxter Health Care Corp	Primary vendor	$138.24
Denville Scientific	Primary vendor	$55.74
VetEquip Inc.	Primary vendor	$77.80
Office Depot	Primary vendor	$12.84
A.G. Scientific	Primary vendor	$124.00
Laboratory Disposable Products	Primary vendor	$312.94
VWR Int\'l Inc.	Primary vendor	$86.27
Columbia University	Primary vendor	$75.00
Santa Cruz Biotechnology	Primary vendor	$91.50
EnzyMax LLC	Primary vendor	$79.00
Software House International	Primary vendor	$193.10
Welco-CGI Gas Tech LLC	Primary vendor	$15.32
Dako	Primary vendor	$135.00
New ENgland Biolabs	Primary vendor	$192.40
Life Technologies Corp.	Primary vendor	$370.63
Ranin Instrucment	Primary vendor	$354.50
Fedex	Primary vendor	$62.82